Welcome to Evgen Pharma plc
Leading the development of sulforaphane-based medicines.
Evgen Pharma is focused on the clinical development of sulforaphane-based medicines for the treatment of cancer and inflammatory diseases.
Our core technology is Sulforadex®, a unique, patented stabilisation method that enables sulforaphane to be delivered as a stable, solid, active ingredient in an oral pharmaceutical product. We are also researching a number of synthetic, stabilised novel analogues of sulforaphane to advance this new class of pharmaceuticals.